Filed before 2025Filed 6 September 2022
Couragene, Inc. raised $2.6M
Couragene, Inc., a biotech company based in Edison, NJ, raised $2.6M in a new equity round, according to a filing dated 6 September 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 6 September 2022
- Round
- Equity round
- Amount sold
- $2.6M
- Offering size
- $4M
- Investors so far
- 7
- Based in
- Edison, NJ
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 18% of the 1,764 tracked raises with an amount filed in 2022, and than 18% of the 142 in biotech.
Couragene, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 22 May 2024 | New filing | $1M | Another raise |
| 6 Sep 2022 | New filing | $2.6M | This raise |
More with Tsingyuan Ventures on the board
- NovoLINC Inc.$10.2M
- iDox.ai Corp.$10.2M
- Persperion Diagnostics Inc.$450K
- Synaptec Health Inc.$4.21M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.